|
|
|
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
5/11/2012 | published by: Kalorama Information
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a
|
more...
|
$3,995.00
|
|
NRT Smoking Cessation Aids in Guatemala
5/10/2012 | published by: Euromonitor International
In 2011 NRT smoking cessation aids grew by 6% to GTQ4 million in current value terms. Although growth is still important, it was affected by decreasing unit prices mainly coming from gum formats. In 2009
|
more...
|
$900.00
|
|
NRT Smoking Cessation Aids in Latvia
5/8/2012 | published by: Euromonitor International
In 2011, tobacco products continued to increase in price, which were already high. This contributed to a growth rate of NRT smoking cessation aids, as more people wanted to stop smoking. The trend of decreasing
|
more...
|
$900.00
|
|
Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
5/21/2012 | published by: GlobalData
Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report
|
more...
|
$3,995.00
|
|
NRT Smoking Cessation Aids in Ukraine
5/10/2012 | published by: Euromonitor International
At the end of the review period Ukrainian smokers had their habit further pressurised by the government’s initiatives to reduce smoking through tax increases and restrictions on public smoking. Smoking in banned places was not
|
more...
|
$900.00
|
|
Hemorrhoids Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Hemorrhoids Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Hemorrhoids Global Clinical Trials Review, H1, 2012 provides data on the Hemorrhoids clinical trial scenario. This report provides elemental information and data relating to the
|
more...
|
$1,000.00
|
|
Hepatic Encephalopathy Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Hepatic Encephalopathy Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Hepatic Encephalopathy Global Clinical Trials Review, H1, 2012 provides data on the Hepatic Encephalopathy clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
|
Hepatic Injury Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Hepatic Injury Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Hepatic Injury Global Clinical Trials Review, H1, 2012 provides data on the Hepatic Injury clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
|
Hepatic Insufficiency Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Hepatic Insufficiency Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Hepatic Insufficiency Global Clinical Trials Review, H1, 2012 provides data on the Hepatic Insufficiency clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
|
Lung Injury Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Lung Injury Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Lung Injury Global Clinical Trials Review, H1, 2012 provides data on the Lung Injury clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
Related Markets
- Diseases & Conditions
- Obesity
- Healthcare
- Public Health
- Pharmaceuticals
- Drug Discovery
- Therapeutic Area
- Behavioral Health
- Smoking Cessation
Smoking Cessation Reports
- The World Market for Over The Counter (OTC) Drugs
- Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge
- Smoking Addiction Global Clinical Trials Review, Q2, 2011
- Lifestyle Disorders Market to 2016 - Limited Pipeline Products and Slow Progress in R&D are Major Concerns
- Smoking Cessation Therapy Area Pipeline Report

